Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.22.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Revenue $ 2,567 $ 1,910
Cost of revenue 1,358 675
Gross profit 1,209 1,235
Operating expenses:    
Sales and marketing 1,629 1,793
Research and development 999 603
General and administrative 2,818 1,978
Total operating expenses 5,446 4,374
Loss from operations (4,237) (3,139)
Other expense, net:    
Interest expense (27) (26)
(Loss) gain on revaluation of warrant liabilities (100) 11
Other expense, net (256) (516)
Total other expense, net (383) (531)
Net loss (4,620) (3,670)
Other comprehensive income 212 465
Comprehensive loss $ (4,408) $ (3,205)
Net (loss) income per share applicable to common shareholders, basic (in dollars per share) $ (0.36) $ (0.34)
Net loss per share applicable to common shareholders, diluted (in dollars per share) $ (0.36) $ (0.34)
Weighted average number of shares outstanding, basic (in shares) 12,728 10,752
Weighted average number of shares outstanding, diluted (in shares) 12,728 10,752